An overview of the efficacy and safety of fenfluramine and mazindol in the treatment of obesity.

Author: ImperialeT F, StahlK A

Paper Details 
Original Abstract of the Article :
To assess the validity of the perceptions that appetite-suppressant drugs are ineffective, potentially addictive, and fraught with side effects, we reviewed the effectiveness and safety of two such drugs with purported low abuse potential in the treatment of obesity: mazindol and fenfluramine hydroc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1001/archfami.2.10.1033

データ提供:米国国立医学図書館(NLM)

Fenfluramine and Mazindol: Reassessing the Role of Appetite-Suppressant Drugs

Obesity, a growing global health concern, often leads individuals to seek weight loss solutions, including appetite-suppressant drugs. This review, like a seasoned scholar sifting through historical medical texts, delves into the efficacy and safety of two such drugs: fenfluramine and mazindol. The authors, like historians meticulously examining the evidence, challenge the perception that these drugs are ineffective, addictive, and fraught with side effects. Their analysis, like a detailed historical map, reveals that fenfluramine and mazindol, when used appropriately and under medical supervision, can be valuable tools in the fight against obesity, offering potential benefits with a manageable risk profile. This review, like a well-researched desert guide, provides a nuanced perspective on the role of appetite-suppressant drugs in weight management.

A Reassessment of Appetite-Suppressant Drugs: A More Balanced Perspective

This review, like a desert oasis challenging conventional beliefs, offers a more nuanced understanding of the role of fenfluramine and mazindol in weight management. The findings suggest that these drugs, when used appropriately and under medical supervision, can be a valuable tool for individuals struggling with obesity, providing a potential pathway to a healthier weight.

Navigating the Weight Loss Landscape: Informed Choices and Responsible Use

This review, like a wise desert nomad offering guidance, emphasizes the importance of making informed choices and using appetite-suppressant drugs responsibly. It underscores the need for careful medical evaluation, monitoring, and adherence to appropriate guidelines for safe and effective use.

Dr. Camel's Conclusion

This review, like a compass guiding us through the vast desert of weight management options, reminds us that the journey to a healthier weight requires a balanced approach. By understanding the potential benefits and risks of various weight loss strategies, including appetite-suppressant drugs, individuals can make informed choices and work with their healthcare providers to create a personalized plan for success.

Date :
  1. Date Completed 1994-03-30
  2. Date Revised 2019-10-23
Further Info :

Pubmed ID

8111484

DOI: Digital Object Identifier

10.1001/archfami.2.10.1033

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.